Genetika+: precision medicine solutions for mental health

Pharmacogenomics. 2022 Jul;23(10):571-574. doi: 10.2217/pgs-2022-0053. Epub 2022 Jul 26.


Genetika+ is developing a precision medicine tool to optimize the treatment of depression by helping physicians find the best drug therapy for their patients. The tool builds on traditional pharmacogenetics, introducing a 'brain-in-a-dish' screening platform for each patient that will overcome the challenge of limited pharmacodynamic knowledge of pharmacogenetics (PGx). In addition to PGx, our platform integrates patient data with innovative blood-derived patient neurons to test all categories of antidepressants and predict the best drug for each patient. This offers patients optimal drug treatment, allowing a faster response, fewer side effects and lower dosing.

Keywords: depression; mental health; neurons; pharmacogenetics; stem cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Drug-Related Side Effects and Adverse Reactions*
  • Humans
  • Mental Health
  • Pharmacogenetics
  • Precision Medicine*